Pemetrexed and cisplatin as first-line chemotherapy for advanced non-small cell lung cancer (NSCLC) with measurable asymptomatic inoperable brain metastases (BM): A multicenter phase II trial (GFPC 07-01).

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. 7595-7595
Author(s):  
G. Robinet ◽  
F. Barlesi ◽  
R. Gervais ◽  
H. Lena ◽  
J. Hureaux ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Brain Metastases ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line ◽  
Multicenter Phase ◽  
Line Chemotherapy

Phase II trial of weekly docetaxel and carboplatin as first line chemotherapy in advanced or metastatic non small cell lung cancer (NSCLC)

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 7330-7330 ◽  
Author(s):  
G. Y. Chahine ◽  
F. L. Nasr ◽  
J. G. Kattan ◽  
F. S. Farhat ◽  
M.-E. El Seoudi ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line ◽  
Weekly Docetaxel ◽  
Line Chemotherapy
Sign in / Sign up

Export Citation Format

Share Document